Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chae Young Han

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancers|November 9, 2024
Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. <i>Cancers</i> 2019, <i>11</i>, 813Michelle K Y Siu, Yu-Xin Jiang, Jing-Jing Wang, et al.
Journal of Ovarian Research|June 6, 2022
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancersBao Kong, Chae Young Han, Se Ik Kim, et al.
Cancer Cell|April 4, 2020
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung CancerHunain Alam, Ming Tang, Mayinuer Maitituoheti, et al.
British Journal of Cancer|January 10, 2024
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancerChae Young Han, Jacob S Bedia, Wei-Lei Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Normal Risk Ovarian Screening Study: 21-Year UpdateChae Young Han, Karen H Lu, Gwen Corrigan, et al.
Cancers|July 24, 2021
Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian CancerChae Young Han, David A Patten, Se Ik Kim, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancers|November 9, 2024
Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. <i>Cancers</i> 2019, <i>11</i>, 813Michelle K Y Siu, Yu-Xin Jiang, Jing-Jing Wang, et al.
Journal of Ovarian Research|June 6, 2022
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancersBao Kong, Chae Young Han, Se Ik Kim, et al.
Cancer Cell|April 4, 2020
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung CancerHunain Alam, Ming Tang, Mayinuer Maitituoheti, et al.
British Journal of Cancer|January 10, 2024
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancerChae Young Han, Jacob S Bedia, Wei-Lei Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Normal Risk Ovarian Screening Study: 21-Year UpdateChae Young Han, Karen H Lu, Gwen Corrigan, et al.
Cancers|July 24, 2021
Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian CancerChae Young Han, David A Patten, Se Ik Kim, et al.
Pageof 2